In section Market Quotes

Humana to Liquidate $900 Million Gentiva Stake

Humana has struck a deal to offload nearly its entire minority interest in the hospice and end-of-life care provider Gentiva. The transaction, involving a consortium of investors, pins the valuation of the insurer’s stake at approximately $900 million as the company moves to streamline its portfolio.

By Money Talk·June 11, 2026·2 min read

Humana to Liquidate $900 Million Gentiva Stake

The health insurer plans to channel the proceeds from the divestiture into general corporate operations. While the company expects the sale to finalize during the third quarter of this year, it has explicitly signaled that the move will not materially alter its 2026 financial projections. Specific financial mechanics behind the agreement remain private.

Investors reacted with caution to the announcement, with Humana shares sliding 1.2% to $360.00 during after-hours trading. This exit marks a shift for the insurer as it looks to shed its secondary holdings in the specialized care sector.

Humana to Liquidate $900 Million Gentiva Stake

Comments (0)